Kenneth Volk - Macerich Exec Devel
| M6G Stock | EUR 18.63 0.72 3.72% |
Insider
Kenneth Volk is Exec Devel of The Macerich
| Age | 60 |
| Phone | 310-394-6000 |
| Web | https://www.macerich.com |
Kenneth Volk Latest Insider Activity
Tracking and analyzing the buying and selling activities of Kenneth Volk against Macerich stock is an integral part of due diligence when investing in Macerich. Kenneth Volk insider activity provides valuable insight into whether Macerich is net buyers or sellers over its current business cycle. Note, Macerich insiders must abide by specific rules, including filing SEC forms every time they buy or sell Macerich'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Kenneth Volk over six months ago Acquisition by Kenneth Volk of 40368 shares of Macerich subject to Rule 16b-3 |
Macerich Management Efficiency
The company has return on total asset (ROA) of 0.0119 % which means that it generated a profit of $0.0119 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0213) %, meaning that it generated substantial loss on money invested by shareholders. Macerich's management efficiency ratios could be used to measure how well Macerich manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Ulf MBA | Diamyd Medical AB | 48 | |
| Robert Douglas | GLOBUS MEDICAL A | 59 | |
| ChanKeun Park | Magnachip Semiconductor | N/A | |
| David Paul | GLOBUS MEDICAL A | 52 | |
| Daniel Lemaitre | GLOBUS MEDICAL A | 65 | |
| Chan Park | Magnachip Semiconductor | 59 | |
| Martina Widman | Diamyd Medical AB | 42 | |
| Kelly Huller | GLOBUS MEDICAL A | 47 | |
| Jing Yang | Genertec Universal Medical | 56 | |
| Theodore Kim | Magnachip Semiconductor | 53 | |
| Anton Lindqvist | Diamyd Medical AB | 43 | |
| Xiaohong Ge | Genertec Universal Medical | N/A | |
| Eva Karlstrom | Diamyd Medical AB | 59 | |
| Shin Park | Magnachip Semiconductor | 42 | |
| Feng Qingming | Genertec Universal Medical | N/A | |
| David Davidar | GLOBUS MEDICAL A | 53 | |
| Ann Rhoads | GLOBUS MEDICAL A | 54 | |
| ACS ACIS | Genertec Universal Medical | N/A | |
| SeungHoon Lee | Magnachip Semiconductor | N/A | |
| YoungJoon Kim | Magnachip Semiconductor | 58 | |
| Wang Wenbing | Genertec Universal Medical | 49 | |
Management Performance
| Return On Equity | -0.0213 | |||
| Return On Asset | 0.0119 |
Macerich Leadership Team
Elected by the shareholders, the Macerich's board of directors comprises two types of representatives: Macerich inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Macerich. The board's role is to monitor Macerich's management team and ensure that shareholders' interests are well served. Macerich's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Macerich's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Zecchini, Senior Vice President Chief Accounting Officer, Principal Accounting Officer | ||
| Kenneth Volk, Exec Devel | ||
| Edward Coppola, President Director | ||
| Ann Menard, Executive Vice President Chief Legal Officer and Secretary | ||
| Thomas CPA, CEO Director | ||
| Robert Beffa, VP Estate | ||
| Scott Kingsmore, CFO, Executive Vice President Treasurer | ||
| Samantha Greening, Director Relations | ||
| Olivia Leigh, Ex People | ||
| Douglas Healey, Executive Vice President - Leasing |
Macerich Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Macerich a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0213 | |||
| Return On Asset | 0.0119 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 6.64 B | |||
| Shares Outstanding | 215.24 M | |||
| Shares Owned By Insiders | 0.70 % | |||
| Shares Owned By Institutions | 83.83 % | |||
| Price To Earning | 41.41 X | |||
| Price To Book | 0.92 X |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Macerich Stock
Macerich financial ratios help investors to determine whether Macerich Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Macerich with respect to the benefits of owning Macerich security.